CML [electronic resource] : genetic paradigm of targeted therapy, part 2 of 2 / Michael W. Deininger.
Material type:
FilmSeries: Henry Stewart talksBiomedical & life sciences collection. Cancer genetics: Publisher: London : Henry Stewart Talks, 2015Description: 1 online resource (1 streaming video file (35 min.) : color, sound)Other title: Chronic myeloid leukemia : genetic paradigm of targeted therapy. Part 2 | CML : genetic paradigm of targeted therapy. Part 2Subject(s): Antineoplastic agents | Cancer -- Genetic aspects | Chronic myeloid leukemia | Drug delivery systems | Protein kinases -- Inhibitors | Antineoplastic Agents -- therapeutic use | Drug Delivery Systems -- methods | Fusion Proteins, bcr-abl -- antagonists & inhibitors | imatinib | Leukemia, Myelogenous, Chronic, BCR-ABL Positive -- drug therapy | Neoplasms -- genetics | Protein Kinase Inhibitors -- therapeutic use | Protein-Tyrosine Kinases -- antagonists & inhibitorsOnline resources: Click here to access online | Series Animated audio-visual presentation with synchronized narration.
Title from title frames.
Contents: Mechanisms of resistance to tyrosine kinase inhibitors (TKIs) -- Overcoming resistance with second and third generation TKIs -- Remaining difficulties in eradicating CML.
Access restricted to subscribers.
Mode of access: World Wide Web.